Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2004
10/21/2004WO2004089938A1 A novel crystalline form of irbesartan
10/21/2004WO2004089937A1 7-membered heterocyclic derivative
10/21/2004WO2004089932A1 Substituted pyrazole compounds
10/21/2004WO2004089931A1 Substituted pyrazoles
10/21/2004WO2004089915A1 Piperazine derivative renin inhibitors
10/21/2004WO2004089914A1 Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds
10/21/2004WO2004089913A1 Aminopyrimidine derivatives and their medical use
10/21/2004WO2004089910A1 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders
10/21/2004WO2004089900A1 Azabicyclo derivatives as muscarinic receptor antagonists
10/21/2004WO2004089892A2 Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity
10/21/2004WO2004089888A1 Pyrazole compounds
10/21/2004WO2004089885A1 Novel compounds
10/21/2004WO2004089367A1 Pharmaceutical use of substituted 1,2,4-triazoles
10/21/2004WO2004089364A1 Azabicyclo derivatives as muscarinic receptor antagonists
10/21/2004WO2004089362A1 2-cyanopyrroles and their analogues as ddp-iv inhibitors
10/21/2004WO2004089286A2 Novel compounds and compositions as protein kinase inhibitors
10/21/2004WO2004076407A3 Pyrrolidine derivatives as oxytocin antagonists
10/21/2004WO2004065380A8 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/21/2004WO2004056786A3 Pyrimidine derivates for the treatment of abnormal cell growth
10/21/2004WO2004043369A3 Sulfonamides
10/21/2004US20040209981 Protective coating for food, beverages, drugs; cosmetics; shampoo; radiation resistance
10/21/2004US20040209939 Pyrrole derivatives
10/21/2004US20040209938 Novel 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/21/2004US20040209935 Pyrazole-derived kinase inhibitors and uses thereof
10/21/2004US20040209908 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments
10/21/2004US20040209905 Quinoline derivatives and quinazoline derivatives
10/21/2004US20040209893 treatment of a condition mediated by a tachykinin including substance P and other neurokinins by administering N-benzyl-2-phenylpiperazine-1-carboxamides, e.g., 2-(4-Fluoro-2-methyl-phenyl)-piperazine-1-carboxylic Acid (3,5-bistrifuoromethyl-benzyl)-methyl-amide Hydrochloride .
10/21/2004US20040209892 Heterocyclic compounds and methods of use
10/21/2004US20040209891 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase IV
10/21/2004US20040209889 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
10/21/2004US20040209882 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
10/21/2004US20040209881 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
10/21/2004US20040209880 e.g., 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3 ,5]triazine-2,4-diamine; inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells and inhibit smooth muscle proliferation.
10/21/2004US20040209879 Piperidinyl derivates as modulators of chemokine receptor activity
10/21/2004US20040209874 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
10/21/2004US20040209865 use for reducing body weight and treating urinary incontinence; Melanin-concentrating hormone (MCH); 5-(4-chloro-phenyl)-2-[5-(2-pyrrolidin-1-yl-ethoxy)-pyridin-2-yl-ethynyl]-pyridine for example
10/21/2004US20040209863 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents
10/21/2004US20040209862 use treating Human Immunodeficiency Virus (HIV) , or genetically related retroviral, infection or a resulting acquired immunodeficiency syndrome (AIDS); 2-[4-(3,5-dichlorobenzyl)-3,5-diethyl-1H-pyrazol-1-yl]ethanol; reverse transcriptase inhibitors
10/21/2004DE10314702A1 Verfahren zur Herstellung von Telmisartan Process for the preparation of telmisartan
10/21/2004CA2522071A1 Azabicyclo derivatives as muscarinic receptor antagonists
10/21/2004CA2521989A1 Azabicyclo derivatives as muscarinic receptor antagonists
10/21/2004CA2521400A1 Piperazine derivative renin inhibitors
10/21/2004CA2521340A1 Aminopyrimidine derivatives and their medical use
10/21/2004CA2521227A1 Substituted pyrazole compounds
10/21/2004CA2521202A1 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders
10/21/2004CA2521201A1 Substituted pyrazoles for use in the prophylaxis or treatment of a disease which can be influenced by the binding of the substitued pyrazoles to 5ht receptors
10/21/2004CA2521199A1 Pyrazole compounds
10/21/2004CA2521184A1 Novel compounds and compositions as protein kinase inhibitors
10/20/2004EP1467989A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
10/20/2004EP1467988A1 Quinazoline(di)ones for invertebrate pest control
10/20/2004EP1467977A1 Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them.
10/20/2004EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
10/20/2004EP1467975A1 Substituted alkyl uracils and the use thereof
10/20/2004EP1467974A1 Benzimidazole derivatives and their use as gnrh antagonists
10/20/2004EP1467972A1 Indazole compounds useful as protein kinase inhibitors
10/20/2004EP1467971A1 Substituted pyrazolines for use as pesticides
10/20/2004EP1467969A2 Dna minor groove binding compounds
10/20/2004EP1467732A1 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases
10/20/2004EP1467731A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
10/20/2004EP1467730A1 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
10/20/2004EP1467727A1 1,3-disubstituted and 1,3,3,-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
10/20/2004EP1467718A1 Method of treatment of a patient requiring analgesia
10/20/2004EP1443045A9 Carbanilide used as pesticide
10/20/2004EP1289964B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/20/2004EP1263725B1 Novel compounds
10/20/2004EP1246619B1 Urotensin-ii receptor antagonists
10/20/2004EP0862555B1 Substituted aryl or heteroarylamides having retinoid-like biological activity
10/20/2004CN1538969A Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins
10/20/2004CN1538967A Heterocyclic compound and antitumour agent containing the same as active ingredient
10/20/2004CN1538956A Spiro compounds
10/20/2004CN1538848A Novel Benzo-fused heterocycles
10/20/2004CN1171880C Pesticidal triazine derivatives
10/19/2004US6806287 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/19/2004US6806286 Pyrrolecarboxamides and pyrrolethioamides as fungicides
10/19/2004US6806274 Quinazoline derivatives
10/19/2004US6806230 Pyrimidine derivatives and herbicides containing them
10/14/2004WO2004087714A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
10/14/2004WO2004087696A1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses
10/14/2004WO2004087695A1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products
10/14/2004WO2004087691A1 A process for the synthesis of losartan potassium
10/14/2004WO2004087690A2 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex
10/14/2004WO2004087679A1 2, 4, 6-trisubstituted pyrimidine derivatives useful for the treatment of neoplastic and autoimmune diseases
10/14/2004WO2004087677A2 Pyrimidin-4-one derivatives and their use as p38 kinase modulators
10/14/2004WO2004087676A1 Method for the production of telmisartan
10/14/2004WO2004087669A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
10/14/2004WO2004087649A2 Benodiazepine spirohydantoin cgrp receptor antagonists
10/14/2004WO2004087053A2 Dipeptidyl peptidase inhibitors
10/14/2004WO2004087050A2 Mitotic kinesin inhibitors
10/14/2004WO2004087048A2 Benzamide modulators of metabotropic glutamate receptors
10/14/2004WO2004078116A3 P38 inhibitors and methods of use thereof
10/14/2004WO2004071448A3 Substituted azole derivatives as inhibitors of protein tyrosine phosphatases
10/14/2004US20040204590 Ep4 receptor agonist, compositions and methods thereof
10/14/2004US20040204588 aryl hydrocarbon; oxidation of 4,5-dihydro-1,3-azoles to fully unsaturated ring; heterocyclic ketones
10/14/2004US20040204498 Pyrimidine carboxamides; 5-hydroxy-2-(2-(1,1-Dioxo-6-[1,2]thiazinan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides; AIDS; AIDS related complex
10/14/2004US20040204477 For use as antiproliferative agents
10/14/2004US20040204454 Lactam-containing cyclic diamines and derivatives as factor Xa inhibitors
10/14/2004US20040204450 For therapy of atherosclerosis, coronary artery disease, coronary heart disease, coronary vascular disease, peripheral vascular disease, dyslipidemia, hyperbetalipoproteinemia, hypoalphalipoproteinemia, hypercholesterolemia, hypertriglyceridemia, familial-hypercholesterolemia
10/14/2004US20040204446 Nitrogen compounds such as N-(2-Fluoro-benzyl)-N-indan-2-yl-2-(3-methyl-2-o-tolyl-piperidin-1-yl) -acetamide, administered for prophylaxis arthritis, psoriasis, cardiovascular disorders, reperfusion injury or respiratory system disorders
10/14/2004US20040204426 4-Imidazolin-2-one compounds
10/14/2004US20040204417 For therapy of cancer
1 ... 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 ... 626